Dunhill Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205 Sell
15
-1
-6% -$12 ﹤0.01% 1261
2026
Q1
$101 Sell
16
-1
-6% -$8 ﹤0.01% 1419
2025
Q4
$119 Buy
17
+11
+183% +$87 ﹤0.01% 1313
2025
Q3
$61 Sell
6
-3
-33% -$29 ﹤0.01% 970
2025
Q2
$92 Sell
9
-15
-63% -$155 ﹤0.01% 963
2025
Q1
$351 Sell
24
-15
-38% -$231 ﹤0.01% 854
2024
Q4
$577 Buy
39
+15
+63% +$244 ﹤0.01% 780
2024
Q3
$459 Hold
24
﹤0.01% 810
2024
Q2
$487 Buy
24
+1
+4% +$20 ﹤0.01% 753
2024
Q1
$431 Buy
23
+4
+21% +$69 ﹤0.01% 716
2023
Q4
$279 Buy
+19
New +$258 ﹤0.01% 709

Other funds holding OGN

Dunhill Financial's OGN Position: Q2 2026 in Review

Dunhill Financial reduced its Organon & Co (OGN) stake by 6.3% in Q2 2026, selling an estimated $12 and leaving 15 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

Dunhill Financial first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $577 in Q4 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Dunhill Financial held 15 shares of Organon & Co worth $205 as of Q2 2026.
  • Dunhill Financial sold 1 Organon & Co share in Q2 2026, an estimated $12.
  • Organon & Co made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1261 holding.
  • Dunhill Financial first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Organon & Co position peaked at $577 in Q4 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.